Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Dethlefs Sven, Vice-Président Exécutif. Director active across 1 company, notably Teva Pharmaceutical Industries Ltd. In total, 6 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €181k. History available since 6 March 2023. The latest transaction was disclosed on 6 March 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Sven Dethlefs is Executive Vice President for North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. In this role, he oversees the company's commercial and strategic operations in the region. His expertise in the pharmaceutical industry is crucial for the development and growth of TEVA.